BANK OF MONTREAL /CAN/ - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 199 filers reported holding IMPAX LABORATORIES INC in Q3 2016. The put-call ratio across all filers is 1,411.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2018$1,030,000
+13.6%
52,929
-2.8%
0.00%0.0%
Q4 2017$907,000
-18.0%
54,4550.0%0.00%0.0%
Q3 2017$1,106,000
+26.4%
54,455
+0.1%
0.00%0.0%
Q2 2017$875,000
+28.5%
54,383
+0.9%
0.00%0.0%
Q1 2017$681,000
+40.4%
53,874
+60.4%
0.00%0.0%
Q4 2016$485,000
-70.5%
33,586
-51.6%
0.00%
-50.0%
Q3 2016$1,643,000
-5.5%
69,343
+15.0%
0.00%0.0%
Q2 2016$1,738,000
-11.3%
60,298
-1.4%
0.00%0.0%
Q1 2016$1,959,000
-25.8%
61,181
-0.9%
0.00%
-33.3%
Q4 2015$2,640,000
+18.0%
61,733
-2.9%
0.00%0.0%
Q3 2015$2,237,000
+176.2%
63,546
+260.0%
0.00%
+200.0%
Q2 2015$810,000
+22.9%
17,652
+25.5%
0.00%0.0%
Q1 2015$659,000
+8.4%
14,067
-26.7%
0.00%0.0%
Q4 2014$608,000
-37.2%
19,181
-53.0%
0.00%0.0%
Q3 2014$968,000
-33.8%
40,803
-16.3%
0.00%
-50.0%
Q2 2014$1,462,000
+7.7%
48,741
-5.2%
0.00%0.0%
Q1 2014$1,357,000
-67.1%
51,405
-68.7%
0.00%
-66.7%
Q4 2013$4,130,000
+22.8%
164,3080.0%0.01%
+20.0%
Q3 2013$3,363,000
-37.1%
164,308
-38.7%
0.01%
-44.4%
Q2 2013$5,347,000268,1390.01%
Other shareholders
IMPAX LABORATORIES INC shareholders Q3 2016
NameSharesValueWeighting ↓
Orbimed Advisors 5,415,600$162,414,0001.91%
Broadfin Capital, LLC 1,217,858$36,524,0001.80%
NEW AMSTERDAM PARTNERS LLC/NY 695,100$20,846,0001.36%
Healthcare Value Capital, LLC 50,000$1,500,0001.26%
Iguana Healthcare Management, LLC 75,000$2,249,0001.05%
Matarin Capital Management, LLC 78,292$2,347,977,0001.04%
Independence Capital Asset Partners, LLC 253,089$7,590,0001.04%
Tekla Capital Management LLC 344,683$10,337,0000.95%
Penn Capital Management Company, LLC 794,641$23,831,0000.92%
Leonard Capital Management, Inc. 87,661$2,629,0000.89%
View complete list of IMPAX LABORATORIES INC shareholders